Presented at EULAR 2025; OP0025. DOI: 10.1136/annrheumdis-2025-eular.B1313 Provided by European Alliance of Associations for Rheumatology, EULAR ...

EULAR Updates Recommendations for Managing Rheumatoid Arthritis Lucy Hicks June 20, 2025 0 ...

In 2023, EULAR welcomed Professor Daniel Aletaha to the role, but it is now time for him to hand the baton on to the next in line. We are delighted to have Xenofon Baraliakos as the new EULAR ...

UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) in psoriatic arthritis and axial spondyloarthritis. The results, presented ...

Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025). The first-in-class biologic, designed as a non-addictive pain treatment, showed ...

BARCELONA, Spain, June 12, 2025--Hospital for Special Surgery (HSS) presented new findings at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting that could help pave the ...

Schmolik, V., et al. (2025) Health services usage in the Austrian osteoarthritis registry show a high level of non-evidence-based therapies. Presented at EULAR 2025; OP0236-HPR. Ann Rheum Dis 2025 ...

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimodRHO data show efgartigimod achieved sustained reduction in ...

BARCELONA, Spain-- (BUSINESS WIRE)--Jun 14, 2025--HSS Study at EULAR 2025 Congress Uses an AI Model to Predict Readmissions of Pregnant Women with Lupus Based on Social Determinants of Health ...

BARCELONA, Spain-- (BUSINESS WIRE)-- Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an ...

Presented at EULAR 2025; OP0232. Ann Rheum Dis 2025; DOI: 10.1136/annrheumdis-2025-eular.A21. Huss V, et al. Rheumatoid arthritis, non-TNFi bDMARDs and JAKi - risks of keratinocyte cancer.

At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind the groundbreaking PrismRA ® test, unveiled a new, AI-driven approach to help doctors better evaluate ...